Exchange: NASDAQ·Updated 04:00 PM EDT
EDSA logo

EDSA Edesa Biotech Inc

$2.57
$0.13
(4.82%)
Today
Mkt Cap$36.48M
Vol30,624.00

About EDSA

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.
37

Bearish Sentiment

How do you feel about EDSA?

Treb3k
$EDSA can we also return to discussing how INSANE it is that they are going with JSS medical research again? you should short the company based on that information alone. its the incompetent leading the incompetent
3
Treb3k
$EDSA are you freaking kidding me… on what grounds did the compensation committee vote for these? this is absolutely absurd… and in the case of par i am starting to think it incentives him to keep the stock down
3
EdV3
$EDSA Here's my current opinion: JB has hit max site activation with a readout sometime late next year. Pari P3 data was compelling BUT trial was truncated, covid data, small sample size, and dataset has yet to be fully published for peer review. All this means is that the asset in not compelling enough as it stands to warrant additional govt investment or BP partnership. That could change very quickly (and reprice very quickly) if the JB data shows clear stat sig mortality reduction benefit. Re EB06, they likely modified the P2 to conserve funds and compress timelines. That's fine. IND is now approved, that's a derisk. They are likely wanting to see an efficacy signal while they plan a larger p2b using a subcutaneous formulation. The risk now is an endpoint one for the small p2 - is 28 weeks enough to allow for a repigmentation signal? Cash on hand probably covers them through early 2028 assuming burn rate doesn't materially increase from that 5-6m/quarter level.
2
EdV3
$EDSA well, a "bit" delayed but that is a solid milestone. I do think there will be a trade here in 27/28 and this is officially back on my watch list. BUT I don't think I'd enter until fpi in US and we see a bit more downside to keep the r/r looking good
2
Treb3k
$EDSA why the huge sell off? and all the uproar? this is one of the strongest investments ive ever had…
2
Moneyybaggs
$EDSA HBC is ALIVE AND WELL!!! Hope you sold when the stock was in the $15-20 range!!! We’re getting close to buying back in!!!
2
ElephantMan101
$EDSA id once again like to reiterate I fucking hate this stock. Give me 20 again and im gone
1
EdV3
$EDSA listen....Velan already rode it to 70 cents once....what makes you think hhey won't sit by and fully roundtrip it? 😂
1
focafoca99
$EDSA increased base salaries for its CEO, President and CFO, with the CEO's pay rising to $657,423 and the President's to $591,681.
JMJTrading
$EDSA take a look at new IPO called IAM - just became available, the first legit IPO in a long time, could see big gains here. Look it up, its my call for the rest of the week! $$$
Rayvio_News_Filter
$EDSA 🏥 Edesa Biotech, Inc. received FDA IND clearance for its Phase 2 clinical study of EB06 in vitiligo, enabling expansion of recruitment to U.S. investigational sites. Prioritized by relevance
jaemin93
$EDSA I sent about three emails, but I didn't get a reply to any of them. What a huge disappointment...
Moneyybaggs
$EDSA So the company sold $25M of common stock at $5.50 per share and each share issued has a warrant attached with a strike price of $7.50 and an expiration of 18 months from the August 21st closing date. It’s obvious to me that those buyers have been selling the shares they received thus having no capital at risk yet still own the warrant risk free. This is why there has been constant selling pressure since August 21st. The stock has almost been cut in half since the pipe was priced at $5.50. It’s starting to look very interesting/attractive.

Advertisement|Remove ads.